1. 2904 Patterns of response and relapse of primary central nervous system lymphomas (PCNSL) following first line of high-dose methotrexate-based chemotherapy (hdMTX): Independent review of a prospective ANOCEF randomized phase II trial. (September 2015) Authors: Tabouret, E.; Houillier, C.; Martin-Duverneuil, N.; Blonski, M.; Soussain, C.; Ghesquieres, H.; Houot, R.; Delwail, V.; Soubeyran, P.; Gressin, R.; Gyan, E.; Lemercier, S.; Chinot, O.; Taillandier, L.; Tanguy, M.L.; Antonio, O.; Hoang-Xuan, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA‐101 TRIAL, A LYSA GROUP STUDY. (12th June 2019) Authors: Le Gouill, S.; Beldi‐Ferchiou, A.; Cacheux, V.; Salles, G.; Canioni, D.; Bodet‐Milin, C.; Alcantara, M.; Delwail, V.; Gastinne, T.; Thieblemont, C.; Maisonneuve, H.; Lamy de la Chapelle, T.; Oberic, l.; Bouabdallah, K.; Ribrag, V.; Delfau‐Larue, M.; Macintyre, E.; Hermine, O. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. R‐CHOP +/‐RADIOTHERAPY IN NON‐BULKY LIMITED‐STAGE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FINAL RESULTS OF THE PROSPECTIVE RANDOMIZED PHASE III 02‐03 TRIAL FROM THE LYSA/GOELAMS. (June 2017) Authors: Lamy, T.; Damaj, G.; Soubeyran, P.; Gyan, E.; Legouill, S.; Cartron, G.; Boubdallah, K.; Gressin, R.; Cornillon, J.; Banos, A.; Ledu, K.; Benchalal, M.; Moles, M.; Fleury, J.; Godmer, P.; Maisonneuve, H.; Deconninck, E.; Laribi, K.; Marolleau, J.; Tournilhac, O. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Use of temozolomide instead of cyclophosphamide in diffuse large B-cell lymphoma. Issue 3 (3rd March 2016) Authors: Cassou-Mounat, T.; Delwail, V.; Cayssials, E.; Terroir, M.; Puyade, M. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 3(2016:Mar.) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗